In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival.
Adolescent
Adult
Aged
Bile Duct Diseases
/ prevention & control
Bile Ducts
/ blood supply
Child
Death
Delayed Graft Function
/ prevention & control
Extracorporeal Circulation
Female
Graft Survival
Humans
Ischemia
/ prevention & control
Liver Transplantation
/ adverse effects
Male
Middle Aged
Organ Preservation
/ adverse effects
Perfusion
/ methods
Retrospective Studies
Temperature
Tissue and Organ Harvesting
/ adverse effects
Tissue and Organ Procurement
/ methods
Young Adult
clinical research/practice
donors and donation: donation after circulatory death (DCD)
extracorporeal membrane oxygenation (ECMO)
liver transplantation/hepatology
surgical technique
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
11
07
2018
revised:
09
11
2018
accepted:
16
12
2018
pubmed:
28
12
2018
medline:
15
7
2020
entrez:
28
12
2018
Statut:
ppublish
Résumé
Livers from controlled donation after circulatory death (DCD) donors suffer a higher incidence of nonfunction, poor function, and ischemic cholangiopathy. In situ normothermic regional perfusion (NRP) restores a blood supply to the abdominal organs after death using an extracorporeal circulation for a limited period before organ recovery. We undertook a retrospective analysis to evaluate whether NRP was associated with improved outcomes of livers from DCD donors. NRP was performed on 70 DCD donors from whom 43 livers were transplanted. These were compared with 187 non-NRP DCD donor livers transplanted at the same two UK centers in the same period. The use of NRP was associated with a reduction in early allograft dysfunction (12% for NRP vs. 32% for non-NRP livers, P = .0076), 30-day graft loss (2% NRP livers vs. 12% non-NRP livers, P = .0559), freedom from ischemic cholangiopathy (0% vs. 27% for non-NRP livers, P < .0001), and fewer anastomotic strictures (7% vs. 27% non-NRP, P = .0041). After adjusting for other factors in a multivariable analysis, NRP remained significantly associated with freedom from ischemic cholangiopathy (P < .0001). These data suggest that NRP during organ recovery from DCD donors leads to superior liver outcomes compared to conventional organ recovery.
Identifiants
pubmed: 30589499
doi: 10.1111/ajt.15241
pii: S1600-6135(22)09118-3
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1745-1758Subventions
Organisme : National Institute for Health Research
Pays : International
Organisme : Evelyn Trust
Pays : International
Organisme : National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU)
Pays : International
Informations de copyright
© 2018 The Authors American Journal of Transplantation published by Wiley Periodicals, Inc. on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons.